newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics Names Adam Veness General Counsel

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced today that Adam Veness, Esq. has joined Cyteir as General Counsel effective tod